These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 34659532)

  • 21. Overexpression of LRRC59 Is Associated with Poor Prognosis and Promotes Cell Proliferation and Invasion in Lung Adenocarcinoma.
    Li D; Xing Y; Tian T; Guo Y; Qian J
    Onco Targets Ther; 2020; 13():6453-6463. PubMed ID: 32753886
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Integrative Analysis of Single-Cell and Bulk RNA Sequencing Reveals Prognostic Characteristics of Macrophage Polarization-Related Genes in Lung Adenocarcinoma.
    Mi K; Zeng L; Chen Y; Yang S
    Int J Gen Med; 2023; 16():5031-5050. PubMed ID: 37942473
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pan-cancer analysis identifies
    Yang H; Wei X; Zhang L; Xiang L; Wang P
    Transl Cancer Res; 2022 Aug; 11(8):2902-2916. PubMed ID: 36093552
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HMGA1 is a Prognostic Biomarker and Correlated with Glycolysis in Lung Adenocarcinoma.
    Ma Y; Ma X; Du B; Li X; Li Y
    J Cancer; 2024; 15(10):2913-2927. PubMed ID: 38706894
    [No Abstract]   [Full Text] [Related]  

  • 25. Overexpression of LncRNA-UCA1 Correlates with Lung Adenocarcinoma Progression and Poor Prognosis.
    Chen L; Cao P; Wu Q; Guo Y; Yang Y; Chen F
    Clin Lab; 2019 Mar; 65(3):. PubMed ID: 30868851
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High expression of glycolysis-related
    Yu H; Yu Z; Qin C; Bian T; Shi M
    J Thorac Dis; 2022 Sep; 14(9):3488-3499. PubMed ID: 36245582
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LINC00628 is differentially expressed between lung adenocarcinoma and squamous cell carcinoma and is associated with the prognosis of NSCLC.
    Liu T; Xu S; Liu X
    Oncol Lett; 2022 Feb; 23(2):55. PubMed ID: 34992687
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic value and immune infiltration of a novel stromal/immune score-related P2RY12 in lung adenocarcinoma microenvironment.
    Yu L; Cao S; Li J; Han B; Zhong H; Zhong R
    Int Immunopharmacol; 2021 Sep; 98():107734. PubMed ID: 34175738
    [TBL] [Abstract][Full Text] [Related]  

  • 29.
    Chen P; Quan Z; Song X; Gao Z; Yuan K
    Front Oncol; 2022; 12():1005962. PubMed ID: 36300089
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High expression of RRM2 as an independent predictive factor of poor prognosis in patients with lung adenocarcinoma.
    Jin CY; Du L; Nuerlan AH; Wang XL; Yang YW; Guo R
    Aging (Albany NY); 2020 Dec; 13(3):3518-3535. PubMed ID: 33411689
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ADAR1 is a prognostic biomarker and is correlated with immune infiltration in lung adenocarcinoma.
    Yang W; Chen K; Yu Q; Liao R; He H; Peng Y; Yang Z; Zhang X
    Cancer Med; 2023 Jul; 12(13):14820-14832. PubMed ID: 37162299
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protein phosphatase 1 regulatory subunit 3G (PPP1R3G) correlates with poor prognosis and immune infiltration in lung adenocarcinoma.
    Zhuo X; Chen L; Lai Z; Liu J; Li S; Hu A; Lin Y
    Bioengineered; 2021 Dec; 12(1):8336-8346. PubMed ID: 34592886
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Elevated FAM83A expression predicts poorer clincal outcome in lung adenocarcinoma.
    Zhang J; Sun G; Mei X
    Cancer Biomark; 2019; 26(3):367-373. PubMed ID: 31594212
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High SERPINH1 expression predicts poor prognosis in lung adenocarcinoma.
    Zhang H; Yan X; Gu H; Xue Q; Liu X
    J Thorac Dis; 2022 Dec; 14(12):4785-4802. PubMed ID: 36647484
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long Non-Coding RNA-TMPO-AS1 as ceRNA Binding to let-7c-5p Upregulates STRIP2 Expression and Predicts Poor Prognosis in Lung Adenocarcinoma.
    Wang J; Yuan Y; Tang L; Zhai H; Zhang D; Duan L; Jiang X; Li C
    Front Oncol; 2022; 12():921200. PubMed ID: 35774125
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of EGFR-Related LINC00460/mir-338-3p/MCM4 Regulatory Axis as Diagnostic and Prognostic Biomarker of Lung Adenocarcinoma Based on Comprehensive Bioinformatics Analysis and Experimental Validation.
    Jia M; Feng S; Cao F; Deng J; Li W; Zhou W; Liu X; Bai W
    Cancers (Basel); 2022 Oct; 14(20):. PubMed ID: 36291859
    [No Abstract]   [Full Text] [Related]  

  • 37. Comprehensive analysis the prognostic and immune characteristics of mitochondrial transport-related gene SFXN1 in lung adenocarcinoma.
    Liu W; Du Q; Mei T; Wang J; Huang D; Qin T
    BMC Cancer; 2024 Jan; 24(1):94. PubMed ID: 38233752
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Decreased INPP5B expression predicts poor prognosis in lung adenocarcinoma.
    Deng J; Lin X; Li Q; Cai XY; Wu LW; Wang W; Zhang B; Li YL; Hu J; Lin NM
    Cancer Cell Int; 2022 May; 22(1):189. PubMed ID: 35568951
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    Xu T; Xu S; Yao Y; Chen X; Zhang Q; Zhao X; Wang X; Zhu J; Liu N; Zhang J; Lin Y; Zou J
    J Thorac Dis; 2022 Feb; 14(2):515-535. PubMed ID: 35280459
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic value of SEC61G in lung adenocarcinoma: a comprehensive study based on bioinformatics and in vitro validation.
    Zheng Q; Wang Z; Zhang M; Yu Y; Chen R; Lu T; Liu L; Ma J; Liu T; Zheng H; Li H; Li J
    BMC Cancer; 2021 Nov; 21(1):1216. PubMed ID: 34774014
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.